Evaluation Study of SPOTme® Skin Cancer Screenings
Completed · Not applicable
Conditions studied: Skin Cancer
In brief
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.
Key facts
- Study ID
- NCT03564769
- Run by
- Harvard School of Public Health (HSPH)
- People needed
- 431
- Starts
- 2017-12-01
- Expected to finish
- 2019-06-01
- Last updated by the study team
- 2019-08-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participated in the American Academy of Dermatology national screening program in 2016 or 2017
- Have a presumptive diagnosis (screening, non-confirmed) of melanoma
- Have provided the AAD with permission to be re-contacted
- Have provided the AAD with an email address
- Aged 18 years or older
- Able to read English
You may not qualify if…
- None
Where it is running
- Harvard TH Chan School of Public Health — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.